Hospital

Pharmacists on the frontlines of the pandemic need to be aware of the latest science and recommendations in order to accurately answer questions.

Today we’re celebrating all of the pharmacists and technicians at the Ann Arbor Veteran’s Affairs (VA) Hospital.

The American Society of Health-System Pharmacists has launched a new, free service to connect health care facilities with pharmacy personnel who can help alleviate potential staffing shortages.

Novartis and Rising Pharmaceuticals are donating doses of hydroxychloroquine to be utilized by researchers investigating safety and efficacy against COVID-19.

New advances in medical therapy have made it possible for rosacea patients to achieve clear skin.

The prevalence of HIV in jails and prisons is approximately 4 times higher than that of the general United States population.

According to the researchers, the case fatality rate for patients with COVID-19 and cardiovascular disease is 10.5%.

Small cell lung cancer is highly aggressive and fast-growing, typically recurring and progressing rapidly despite the initial response to chemotherapy.

During the COVID-19 pandemic, pharmacists are concerned not only about shortages in drugs that could treat the virus, but also medications for managing other conditions.

Curtis E. Haas, PharmD, FCCP, editor-in-chief of Pharmacy Times: Directions in Health-System Pharmacy, and chief pharmacy officer for the University of Rochester’s health care system, discusses preparation for potential patient surge due to COVID-19.

Recent estimates indicate that less than 10% of patients who are at risk for acquiring HIV are prescribed PrEP.

Ed Cohen, PharmD, FAPhA, executive vice president of pharmacy advocacy for the publication, was recognized with the prestigious Individual Advocate of the Year award.

These professional organizations are aware that some medications are being prophylactically prescribed as potential treatments for COVID-19.

The EUA designation allows the test to be used to detect SARS-CoV-2, the virus that causes COVID-19, for the duration of the continuing pandemic.

While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.

Gunda Siska, RPh, PharmD, discusses what she is doing as a hospital pharmacist to stay healthy.

The new guidelines recommend dosing vancomycin to achieve an area under the curve to minimum inhibitor concentration (AUC/MIC) ratio of ≥ 400.

Not enough people are taking seriously frequent recommendations to practice social distancing, he said.

The COVID-19 High Performance Computing Consortium is a partnership of federal government, tech industry, and academic leaders whose goal is to stop the virus.

Only 15% of those at risk are currently using PrEP.

The 12 groups represent practice settings of nearly all pharmacists in the United States.

A new report from the CDC has found that a significant portion of hospitalizations in the United States have come from younger adults.

Marilyn Bulloch, PharmD, BCPS, FCCM, shares her perspective of how the global COVID-19 pandemic is impacting pharmacy in her Alabama community.

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

Chloroquine and remdesivir are not FDA-approved for a COVID-19 indications.

The researchers found that the average yearly out-of-pocket spending by patients with diabetes is over $1,800.

The availability of personal protective equipment, including face masks, gloves and hand sanitizers, have been a concern to many pharmacists.

The goals of the expansion are to maintain social distancing and to avoid overburdening hospitals with patients.

Aimmune’s peanut allergen power was approved by the FDA as an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

The new guidance for industry (GFI) document, “Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products,” was released Saturday.